#FarmGTEx we're getting much better information) and nobody has the money to do that kind of cell biology in large mammals. We can now do knock-outs for validation of early embryonic lethals, which is nice (Ortega et al., 2022, doi.org/10.1101/2021...). It's unfortunate that there isn't enough
0
0
1
0
